One-Year Swallowing Outcomes in Patients Treated with Prophylactic Gabapentin During Radiation-Based Treatment for Oropharyngeal Cancer
- 15 February 2017
- journal article
- research article
- Published by Springer Nature in Dysphagia
- Vol. 32 (3) , 437-442
Abstract
Recent investigations by our study team have demonstrated patients using gabapentin for pain management during chemoradiotherapy (CRT) do well maintaining swallowing during treatment with less need for narcotic pain medication, PEG dependence, weight loss, and short-term swallowing morbidity. The purpose of this investigation was to characterize the long-term swallowing function of these patients 1-year following treatment. Sequential patients receiving CRT for oropharyngeal cancer and concurrent gabapentin were evaluated 1-year following treatment for swallowing outcomes. Functional Oral Intake Scores (FOIS) were utilized to assess diet level. The MD Anderson Dysphagia Inventory (MDADI) was chosen to evaluate patient perception of swallowing function. Videofluoroscopic swallowing studies were completed approximately 1 year after treatment to assess physiologic outcomes as well as Penetration Aspiration Scores (PAS). Data from 26 consecutive participants were available for analysis. The majority of patients had advanced stage disease (Stage 3–4). No patients had a PEG tube 1-year following treatment, and the mean FOIS score was 6.83. Pharyngeal deficits were infrequent with reduced pharyngeal constriction and prominence/early closure of cricopharyngeus predominating. Mean PAS score was 1.5, indicating that the majority of patients had either no laryngeal penetration/aspiration, or transient penetration that was fully cleared. Mean MDADI score was 85.52, indicating that, in general, patients perceived their swallowing to be minimally impaired. Patients receiving gabapentin pain management as part of a comprehensive dysphagia prevention protocol during CRT have excellent long-term swallowing outcomes as reflected in diet levels, physiologic functioning, and patient-perceived quality of life.Keywords
This publication has 22 references indexed in Scilit:
- Predictive Factors for Prophylactic Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement and Use in Head and Neck Patients Following Intensity-Modulated Radiation Therapy (IMRT) Treatment: Concordance, Discrepancies, and the Role of GabapentinDysphagia, 2016
- Adherence to preventive exercises and self‐reported swallowing outcomes in post‐radiation head and neck cancer patientsHead & Neck, 2013
- Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx CancerJournal of Clinical Oncology, 2013
- “Pharyngocise”: Randomized Controlled Trial of Preventative Exercises to Maintain Muscle Structure and Swallowing Function During Head-and-Neck ChemoradiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Prophylactic Swallowing Exercises in Patients With Head and Neck Cancer Undergoing ChemoradiationA Randomized TrialProphylactic Exercises in HNCJAMA Otolaryngology–Head & Neck Surgery, 2012
- Gabapentin for the treatment of pain syndrome related to radiation‐induced mucositis in patients with head and neck cancer treated with concurrent chemoradiotherapyCancer, 2010
- Neuropathic and nociceptive pain in head and neck cancer patients receiving radiation therapyHead & Neck Oncology, 2009
- Gabapentin for the treatment of pain related to radiation‐induced mucositis in patients with head and neck tumors treated with intensity‐modulated radiation therapyHead & Neck, 2009
- Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature reviewRadiotherapy and Oncology, 2003
- A penetration-aspiration scaleDysphagia, 1996